Serrata (serratopeptidase) coated enteric tablets 10 mg. №150


Surgical diseases: sprain and tearing of ligaments, fractures and dislocations, edema caused by plastic surgery; respiratory disease; diseases of the ENT organs; acute inflammatory dermatoses; stagnation in the mammary glands.

Category: Manufacturer: India


Composition and release form
Serrata is available in enteric-coated tablets. The main active ingredient of the drug is serratiopeptidase.
Serrata has a variety of pharmacological effects, which allows it to be used in a wide variety of areas of medicine. In surgery, the drug is used in the treatment of fractures, dislocations, sprains and edema of various etiologies. In addition, Serrata is used to prevent transplant rejection.
Serrata is also used in plastic surgery to improve blood microcirculation, to prevent transplant rejection and reduce edema after surgery.
In ENT practice, the drug is used to treat otitis media, sinusitis and other inflammatory diseases, accompanied by increased secretion production and difficulty in sputum discharge.
In dermatology, the drug is used for the treatment of acute dermatoses, and in gynecology and obstetrics to reduce edema of the mammary glands of various origins. In addition, the drug is very often used to quickly eliminate hematomas.
In addition, Serrata is prescribed to reduce the viscosity of sputum in respiratory diseases.
Serrata is not prescribed for patients with hypersensitivity to serratiopeptidase, bleeding disorders, and a tendency to bleed. The drug is prescribed with caution to those who suffer from impaired kidney or liver function, pregnant women and women at the lactation stage. In pediatric practice, the drug is used for the treatment of children only for vital signs and under medical supervision.
Application during pregnancy and lactation
Serrata does not have teratogenic or mutagenic effects on the fetus, but the experience of prescribing the drug to pregnant women is very limited, therefore it is carried out only for vital signs and under medical supervision.
When prescribing Serrata to women at the lactation stage, breastfeeding should be abandoned.
Method of administration and dosage
Serrata is available as an oral tablet. The drug is taken regardless of food intake, the tablets are swallowed whole. The duration of therapy and the dose of the drug depends on the dynamics and nature of the disease. The standard dose is 1 tablet 3 r / d, if necessary, the amount of the drug can be increased by the doctor’s decision.
When taking increased doses of Serrata, the patient has an increase in side effects. When taking large doses of the drug, internal bleeding may develop. If an overdose symptoms are detected in a patient, the appointment of symptomatic treatment is indicated.
Side effects
When treating Serrata, the patient may develop side effects such as stool disturbance, dyspeptic disorders, abdominal pain, loss of appetite, nosebleeds, sputum production with blood and the development of various allergic reactions.
Storage conditions and periods
Serrata is stored in a cool and dry place. The shelf life of the drug is 24 months.